[PDF][PDF] Pangenomic classification of pituitary neuroendocrine tumors

…, A Septier, F Letourneur, S Diry, M Diedisheim… - Cancer cell, 2020 - cell.com
Pituitary neuroendocrine tumors (PitNETs) are common, with five main histological subtypes:
lactotroph, somatotroph, and thyrotroph (POU1F1/PIT1 lineage); corticotroph (TBX19/TPIT …

Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes

…, L Cagninacci, B Kiaf, M Oshima, M Diedisheim… - Nature …, 2017 - nature.com
Type 1 diabetes (T1D) is an autoimmune disease that results from the destruction of pancreatic
β-cells by the immune system that involves innate and adaptive immune cells. Mucosal-…

[HTML][HTML] Regulation of inflammation in diabetes: From genetics to epigenomics evidence

M Diedisheim, E Carcarino, C Vandiedonck… - Molecular …, 2020 - Elsevier
Background Diabetes is one of the greatest public health challenges worldwide, and we still
lack complementary approaches to significantly enhance the efficacy of preventive and …

[PDF][PDF] Conventional and neo-antigenic peptides presented by β cells are targeted by circulating naïve CD8+ T cells in type 1 diabetic and healthy donors

…, M Bugliani, P Marchetti, M Armanet, M Diedisheim… - Cell metabolism, 2018 - cell.com
Although CD8 + T-cell-mediated autoimmune β cell destruction occurs in type 1 diabetes (T1D),
the target epitopes processed and presented by β cells are unknown. To identify them, …

[HTML][HTML] Genetic inhibition of CARD9 accelerates the development of atherosclerosis in mice through CD36 dependent-defective autophagy

…, P Bruneval, C Guérin, M Diedisheim… - Nature …, 2023 - nature.com
Caspase recruitment-domain containing protein 9 (CARD9) is a key signaling pathway in
macrophages but its role in atherosclerosis is still poorly understood. Global deletion of Card9 …

Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID‐19 in type 2 diabetes

F Alzaid, JB Julla, M Diedisheim, C Potier… - EMBO molecular …, 2020 - embopress.org
Early in the COVID ‐19 pandemic, type 2 diabetes (T2D) was marked as a risk factor for
severe disease and mortality. Inflammation is central to the aetiology of both conditions where …

[HTML][HTML] Modeling human pancreatic beta cell dedifferentiation

M Diedisheim, M Oshima, O Albagli, CW Huldt… - Molecular …, 2018 - Elsevier
Objective Dedifferentiation could explain reduced functional pancreatic β-cell mass in type 2
diabetes (T2D). Methods Here we model human β-cell dedifferentiation using growth factor …

[HTML][HTML] Virus-like infection induces human β cell dedifferentiation

M Oshima, KP Knoch, M Diedisheim, A Petzold… - JCI insight, 2018 - ncbi.nlm.nih.gov
Type 1 diabetes (T1D) is a chronic disease characterized by an autoimmune-mediated
destruction of insulin-producing pancreatic β cells. Environmental factors such as viruses play an …

Diabetes increases severe COVID-19 outcomes primarily in younger adults

M Diedisheim, E Dancoisne, JF Gautier… - The Journal of …, 2021 - academic.oup.com
Context Diabetes is reported as a risk factor for severe coronavirus disease 2019 (COVID-19),
but whether this risk is similar in all categories of age remains unclear. Objective To …

[HTML][HTML] JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm

…, L Arrive, Z Mallat, S Taleb, M Diedisheim… - Nature …, 2022 - nature.com
JAK2V617F mutation is associated with an increased risk for athero-thrombotic cardiovascular
disease, but its role in aortic disease development and complications remains unknown. …